Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

HQ
700 Chesapeake Drive
Redwood City, CA, 94063
USA

People

Board Member

Funding

Tags

Pulmonx

Pulmonx Corporation, based in Redwood City, Calif., is focused on developing and marketing minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.

The company is currently engaged in the design, development and manufacture of products that will improve the effectiveness and benefits of endoscopic lung volume reduction (ELVR) for patients with severe emphysema. The company’s Zephyr® Endobronchial Valve (EBV) therapy* involves placing small one-way valves in the lung to prevent air from entering the most diseased regions while allowing fluids and trapped air to escape. The goal is to reduce the volume of the diseased portions of the lung, allowing increased ventilation to healthier areas of the lung.

The company has CE mark for the Zephyr Endobronchial Valves and has submitted a CE mark application for the Chartis System. The company has 510(k) marketing clearance for the Chartis System in the United States.

Recent Milestones

Videos

Screenshots

Pulmonx screenshot
Above: Home Page
Uploaded: 1/16/10

Sources

  1. Lung-device maker Pulmonx draws in $20M (venturebeat.com) [edit]
  2. Pulmonx Inhales Last Of $11.5M Insider Bridge Round (fis.dowjones.com) [edit]
  3. Pulmonx, Inc.: Series C $32M (onbiovc.com) [edit]
  4. Pulmonx Raises US$10 Million In Series D Financing (researchviews.com) [edit]
Edit This Page
Last Edited 2/25/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy